Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
Judith Bjöhle(Karolinska University Hospital), Thomas Hatschek(Karolinska University Hospital), Mårten Fernö(Lund University), Lena Carlsson(University of Gothenburg), Thomas Walz(Rockefeller University), Barbro Linderholm(Karolinska University Hospital), Martin Malmberg(Skåne University Hospital), Jonas Bergh(Karolinska Institutet), Jenny Bergqvist(Lund University), Hemming Johansson(Karolinska Institutet), M. Sundquist(Landstinget i Kalmar län), Niklas Loman(Lund University), J. Simon Gronowitz(Uppsala University), Martin Söderberg(Uppsala University Hospital), Zakaria Einbeigi(Sahlgrenska University Hospital)
Cited by 39
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k